SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the investment community speculates that controversies surrounding a key FDA official will pave the way for accelerated approval of its Duchenne muscular dystrophy therapy, deramiocel. This comes ahead of the company's highly anticipated Phase 3 data presentation next week, fueling optimism for a potential short squeeze and significant upside.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is experiencing significant volatility amid widespread community outrage and strong speculation regarding the FDA's stance on its Huntington's disease gene therapy, AMT-130, with many now discussing a potential regulatory reversal or a "softball" path forward after an initial setback.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Conflicting reports regarding Oracle's data center expansion with OpenAI in Texas are fueling intense community debate, with perspectives split on whether a potential cancellation benefits Oracle's debt management or signals broader challenges for its AI strategy ahead of upcoming earnings.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is captivating the market with exceptional relative strength and surging volume, hitting new 52-week highs amidst broader market downturns, as the community actively speculates on a looming short squeeze and potential buyout, affirming its undervalued cell therapy platform.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as investor enthusiasm for defense technology and anticipated US military drone contracts drives massive trading volume and price appreciation, despite mixed community reactions regarding its performance in a recent drone competition.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending due to a notable sell-off after its affiliated drone entries were not selected in a government gauntlet, despite recently securing new orders for counter-drone systems from Middle East defense clients. Community discussions are sharply divided between those who view the gauntlet outcome as insignificant to Ondas' broader defense strategy, and frustrated investors who cite persistent market manipulation hindering any sustained upward movement.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is trending as NVIDIA's multi-billion-dollar investment to secure optical components for AI infrastructure fuels significant analyst upgrades and S&P 500 inclusion speculation. The community is sharply divided, debating LITE's soaring valuation and recent insider sales against the sector's robust demand and persistent short squeeze.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings Co (VRT) is trending as the community speculates on its imminent S&P 500 inclusion following a strong Q4 earnings report highlighting explosive demand for its AI data center cooling and power management solutions. Investors are actively debating whether its recent surge reflects sustainable AI infrastructure growth or a potential "sell the news" event.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending due to its imminent uplisting to the NYSE and recent significant government funding to expand its domestic antimony production, positioning it as a crucial player in national security. The community is actively discussing the company's strategic importance as the sole American vertically integrated antimony producer and the added value from its newly announced multi-billion dollar tungsten deposit, amidst increasing global demand for critical minerals.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as escalating geopolitical tensions in the Middle East, coupled with rising oil prices, fuels speculation of increased market volatility, with the community actively discussing its use as a hedge against potential broader market downturns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Estimates Senseonics FY2030 Earnings

Senseonics Holdings, Inc. (NYSE:SENS - Free Report) - Equities researchers at HC Wainwright issued their FY2030 earnings per share estimates for shares of Senseonics in a research note issued to...

Wall Street Analysts Predict a 124.49% Upside in Senseonics (SENS): Here's  What You Should Know

The consensus price target hints at a 124.5% upside potential for Senseonics (SENS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Senseonics Holdings, Inc. Common Stock Q4 Earnings Call Highlights

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) reported fourth-quarter and full-year 2025 results highlighted by the U.S. ramp of its Eversense 365 continuous glucose monitor (CGM), a major...

Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of -7.80% and +0.70%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Preview: Senseonics Holdings's Earnings

Enovis (ENOV) Q4 Earnings Beat Estimates

Enovis (ENOV) delivered earnings and revenue surprises of +17.28% and -1.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

SENS Eversense 365 Integrated With twiist Gains Full Availability

Senseonics rolls out Eversense 365 integrated with Sequel's twiist AID system, aiming to boost CGM adoption with its year-long wear advantage.

Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of "Buy" from Brokerages

Shares of Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) have been assigned a consensus rating of "Buy" from the six ratings firms that are presently covering the stock, MarketBeat Ratings...

All You Need to Know About Senseonics (SENS) Rating Upgrade to Buy

Senseonics (SENS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Senseonics (SENS) Moves 5.3% Higher: Will This Strength Last?

Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.68	--	--	N/A
Q4 '25	-$0.44	-$0.46	-5.68%	MISSED
Q3 '25	-$0.37	-$0.43	-15.06%	MISSED
Q2 '25	-$0.02	-$0.40	-1900.00%	MISSED
Q1 '25	-$0.02	-$0.02	11.11%	BEAT

SENS
Senseonics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest SENS News

SENSSenseonics Holdings Inc